Join
Live feed
·
INSIDERFilingvia Quantisnow
Indivior Pharmaceuticals Inc. logo

Chief Scientific Officer Heidbreder Christian converted options into 101,544 shares and covered exercise/tax liability with 45,797 shares, increasing direct ownership by 29% to 246,509 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INDV (Indivior Pharmaceuticals Inc.) and more on Quantisnow.